Unknown

Dataset Information

0

Targeting Akt3 signaling in triple-negative breast cancer.


ABSTRACT: Triple-negative breast cancer (TNBC) is currently the only major breast tumor subtype without effective targeted therapy and, as a consequence, in general has a poor outcome. To identify new therapeutic targets in TNBC, we performed a short hairpin RNA (shRNA) screen for protein kinases commonly amplified and overexpressed in breast cancer. Using this approach, we identified AKT3 as a gene preferentially required for the growth of TNBCs. Downregulation of Akt3 significantly inhibits the growth of TNBC lines in three-dimensional (3D) spheroid cultures and in mouse xenograft models, whereas loss of Akt1 or Akt2 have more modest effects. Akt3 silencing markedly upregulates the p27 cell-cycle inhibitor and this is critical for the ability of Akt3 to inhibit spheroid growth. In contrast with Akt1, Akt3 silencing results in only a minor enhancement of migration and does not promote invasion. Depletion of Akt3 in TNBC sensitizes cells to the pan-Akt inhibitor GSK690693. These results imply that Akt3 has a specific function in TNBCs; thus, its therapeutic targeting may provide a new treatment option for this tumor subtype.

SUBMITTER: Chin YR 

PROVIDER: S-EPMC3946502 | BioStudies | 2014-01-01

REPOSITORIES: biostudies

Similar Datasets

2020-01-01 | S-EPMC7318068 | BioStudies
2016-01-01 | S-EPMC5071179 | BioStudies
2008-01-01 | S-EPMC2518259 | BioStudies
1000-01-01 | S-EPMC2570525 | BioStudies
2016-01-01 | S-EPMC4704820 | BioStudies
2011-01-01 | S-EPMC3204738 | BioStudies
2020-01-01 | S-EPMC7291172 | BioStudies
2012-01-01 | S-EPMC3189303 | BioStudies
2017-01-01 | S-EPMC5339564 | BioStudies
2015-01-01 | S-EPMC4496225 | BioStudies